Medicare Enrolled

Dr. Matthew Rutman, MD

Urology Physician · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
161 FORT WASHINGTON AVE, New York, NY 10032
2123050114
In practice since 2006 (20 years)
NPI: 1083650170 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rutman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rutman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rutman

Dr. Matthew Rutman is an urology physician in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rutman performed 3,244 Medicare services across 2,783 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rutman received a total of $129,012 from 32 pharmaceutical and/or device companies across 221 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rutman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 26% volume in NY $129,012 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,244
Medicare services
Top 26% in NY for urology physician
2,783
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~162 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
1,036 $10 $200
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
829 $108 $530
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
322 $11 $340
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
200 $142 $660
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
169 $220 $1,500
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
165 $96 $480
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
102 $78 $380
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
95 $153 $740
Non-needle muscle activity measurement of bladder and bowel openings
This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles.
62 $30 $1,140
Abdominal device insertion with pressure and urine flow study
A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate.
62 $182 $1,330
Complex urodynamic pressure flow study
A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning.
50 $340 $1,860
Laser vaporization of prostate
A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment.
44 $639 $10,830
Voiding cystourethrogram
An imaging procedure that uses X-rays to visualize the bladder and urethra while urine is being passed.
24 $98 $1,100
Radiologist review of bladder and urethra images with contrast
A radiologist reviews medical images of the urinary bladder and urethra taken with contrast dye, including images captured after the patient has urinated.
23 $96 $410
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
20 $69 $500
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
17 $56 $470
Insertion of temporary bladder tube 12 $43 $380
Complex urodynamic pressure measurement
A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures.
12 $352 $2,010
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$129,012
Total received (2018-2024)
Avg $18,430/year across 7 years
Top 3% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
221
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$93,896 (72.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$29,950 (23.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,166 (4.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$11,039
2023
$12,286
2022
$12,071
2021
$10,859
2020
$8,173
2019
$39,950
2018
$34,636

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Laborie Medical Technologies Corp.
$10,269
PROCEPT BioRobotics Corporation
$247
Sumitomo Pharma America, Inc.
$232
ABBVIE INC.
$117
Medtronic, Inc.
$89
UROGEN PHARMA, INC.
$47
Ambu Inc.
$37
Top 3 companies account for 97.4% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$75,144
Laborie Medical Technologies Corp.
$35,632
BOSTON SCIENTIFIC CORPORATION
$6,750
Ferring Pharmaceuticals Inc.
$4,937
PROCEPT BioRobotics Corporation
$1,305
Medtronic USA, Inc.
$905
Astellas Pharma US Inc
$596
Endo Pharmaceuticals Inc.
$500
C. R. Bard, Inc. & Subsidiaries
$499
Dr.Reddy's Laboratories,Inc.
$450
NeoTract Inc.
$296
Sumitomo Pharma America, Inc.
$285
Allergan Inc.
$283
ABBVIE INC.
$194
Axonics, Inc.
$175
Coloplast Corp
$137
DENTSPLY IH Inc.
$114
Hollister Incorporated
$112
Medtronic, Inc.
$103
Janssen Biotech, Inc.
$84
Rochester Medical Corporation
$82
UROVANT SCIENCES INC
$81
Allergan, Inc.
$76
UROGEN PHARMA, INC.
$47
180 Medical, Inc.
$41
Antares Pharma, Inc.
$40
Ambu Inc.
$37
AbbVie Inc.
$31
Avadel Specialty Pharmaceuticals, LLC
$29
TOLMAR Pharmaceuticals, Inc.
$20
AbbVie, Inc.
$13
PFIZER INC.
$12
Top 3 companies account for 91.1% of all-time payments
Associated products mentioned in payments ›
ADVANTAGE FIT · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AquaBeam Robotic System · BOTOX · BOTOX - UROLOGY · BOTOX COSMETIC · BYSTOLIC · Bulkamid · DALVANCE · ELIGARD · ENTERRA · ERLEADA · GEMTESA · GENERAL BPH · GENERAL BPH · GENERAL THERAPIES · GENERAL - BPH · GENERAL BPH · GENERAL THERAPIES · GENTLECATH · GREENLIGHT · General - BPH · GreenLight XPS · INTERSTIM · INTERSTIM ICON · JELMYTO · LoFric · Lupron · MAGIC3 · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · ONLI · PREMARIN · REZUM · SPEEDICATH · SpeediCath · THERAPIES · UroLift · VaPro · VaPro Pocket · XENFORM · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (73%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for urology physician in NY.

Looking for an urology physician in New York?
Compare urology physicians in the New York area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
751
Per 100K population
46.1
County median income
$104,553
Nearest hospital
NEW YORK STATE PSYCHIATRIC INSTITUTE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rutman is a clinical cardiology specialist, with above-average Medicare volume (top 26% in NY), with speaking/promotional industry engagement in the top 3% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rutman experienced with bladder ultrasound after voiding?
Based on Medicare claims data, Dr. Rutman performed 1,036 bladder ultrasound after voiding services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rutman receive payments from pharmaceutical companies?
Yes. Dr. Rutman received a total of $129,012 from 32 companies across 221 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rutman's costs compare to other urology physicians in New York?
Dr. Rutman's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rutman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →